Detail akcie MindWalk Hldg Rg online

Business Summary: MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Financial Summary: BRIEF: For the six months ended 31 October 2025, MindWalk Holdings Corp revenues increased 41% to C$7.3M. Net loss before extraordinary items decreased 6% to C$7.3M. Revenues reflect Cryo storage revenue segment increase of 3% to C$99K, Europe segment increase from C$160K to C$1.4M, Other segment increase from C$24K to C$550K. Lower net loss reflects Amortization of intangible assets decrease from C$1M (expense) to C$0K.